integrated DNA technologies SRL
175.8 FTEThe score of integrated DNA technologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +18 % Equity -20 % Total assets -10 % Headcount (avg FTE) -2 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
integrated DNA technologies's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €57.2m | ||||
| Net result | €7.73m | ||||
| Equity | €15.4m | ||||
| Cash | €7.35m | ||||
| EBITDA | €5.75m | ||||
| Total assets | €27.4m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
integrated DNA technologies's financial analysis
- Solvency56.2%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of integrated DNA technologies
integrated DNA technologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0473.291.407
- VAT number
- BE0473291407
- Peppol
- Registered · 0208:0473291407 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Nov 2000
- Registered office
- 3001 Leuven
- Size
- Medium · 175.8 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Manufacture of other organic basic chemicals (NACE 20140)
integrated DNA technologies (SRL) has been based in Leuven since 2000, active in: manufacture of other organic basic chemicals. For 2025, it reports revenue of €57.2m, a net profit of €7.73m and equity of €15.4m. With 175.8 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 56.2%, above the median of its sector (48.8%).
Companies similar to integrated DNA technologies
Companies in the same business, of comparable size and area, outside its group.
- LaCAR MDx technologies Manufacture of other special-purpose machinery n.e.c. Liège · balance sheet €29.1m
- Univercells Technologies Manufacture of other chemical products n.e.c. Nivelles · balance sheet €16.2m
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- Unisensor Manufacture of basic pharmaceutical products Seraing · balance sheet €19.2m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- CellCarta Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €22.4m
Frequently asked questions about integrated DNA technologies
What is the revenue of integrated DNA technologies?
According to the 2025 annual accounts filed with the NBB, the revenue of integrated DNA technologies amounts to 57,152,038 €.
What is the VAT number of integrated DNA technologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0473291407 for integrated DNA technologies, if the company is VAT-registered. Its company number (CBE) is 0473.291.407.
Where is the registered office of integrated DNA technologies?
According to the CBE register, the registered office of integrated DNA technologies is in 3001 Leuven.
What is the equity of integrated DNA technologies?
At the close of the 2025 financial year, the equity of integrated DNA technologies amounts to 15,400,177 €, a solvency of 56.2% of total assets.
How many people work at integrated DNA technologies?
175.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages integrated DNA technologies?
The register lists 2 active mandates at integrated DNA technologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of integrated DNA technologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →